Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.145 USD | -2.97% | +9.43% | +6.42% |
May. 09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
Business Summary
Number of employees: 72
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 15 | 100.0 % | 9 | 100.0 % | -39.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 | |
Gary S. Hogge
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-01-31 |
Ioana C. Hone
IRC | Investor Relations Contact | - | - |
George Samuel
LAW | General Counsel | 43 | 21-08-31 |
Derek Kelaita
PRN | Corporate Officer/Principal | - | 19-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Director/Board Member | 66 | 14-04-10 | |
Don Bailey
BRD | Director/Board Member | 78 | 20-02-29 |
Angus Russell
BRD | Director/Board Member | 68 | 14-12-08 |
Michael Mulroy
CHM | Chairman | 58 | 14-10-03 |
Director/Board Member | 67 | 21-05-03 | |
Dipti Amin
BRD | Director/Board Member | 60 | 21-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 188,798,145 | 187,985,347 ( 99.57 %) | 0 | 99.57 % |
Company contact information
Lineage Cell Therapeutics, Inc.
2173 Salk Avenue Suite 200
92008-7354, Carlsbad
+442 287 8990
http://www.lineagecell.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.42% | 223M | |
+19.44% | 47.02B | |
+48.77% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.74% | 26.05B | |
-21.89% | 19.15B | |
+4.11% | 12.55B | |
+29.32% | 12.34B | |
-3.76% | 11.82B |
- Stock Market
- Equities
- LCTX Stock
- Company Lineage Cell Therapeutics, Inc.